Early research (Phase 1)Ended earlyNCT01032122What this trial is testingRituximab in Metastatic MelanomaWho this might be right forMetastatic Melanoma Medical University of Vienna 9
Large-scale testing (Phase 3)Study completedNCT01006980What this trial is testingVemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)Who this might be right forMalignant Melanoma Hoffmann-La Roche 675
Large-scale testing (Phase 3)Study completedNCT01584648What this trial is testingA Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant MelanomaWho this might be right forMelanoma Novartis Pharmaceuticals 423
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT03112668What this trial is testingAcceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersWho this might be right forMalignant Female Reproductive System NeoplasmMalignant Hepatobiliary NeoplasmPartner+36 more Rutgers, The State University of New Jersey 14
Not applicableStudy completedNCT02857374What this trial is testingIntravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node BiopsyWho this might be right forStage IB Skin MelanomaStage IIA Skin MelanomaStage IIB Skin Melanoma+4 more Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT02392871What this trial is testingRadiotherapy & Combi in Metastatic MelanomaWho this might be right forMetastatic Melanoma Melanoma and Skin Cancer Trials Limited 10
Not applicableActive Not RecruitingNCT04990726What this trial is testingImmune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint InhibitorsWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+5 more M.D. Anderson Cancer Center 126
Early research (Phase 1)Ended earlyNCT01835184What this trial is testingCabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+3 more National Cancer Institute (NCI) 5
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT01636882What this trial is testingCAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)Who this might be right forMelanoma Viralytics 16
Early research (Phase 1)Active Not RecruitingNCT03769155What this trial is testingVX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D MelanomaWho this might be right forPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8Pathologic Stage IIID Cutaneous Melanoma AJCC v8 Emory University 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT02910700What this trial is testingNivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV MelanomaWho this might be right forMetastatic Malignant Neoplasm in the BrainMetastatic MelanomaStage III Cutaneous Melanoma AJCC v7+5 more M.D. Anderson Cancer Center 52
Not applicableEnded earlyNCT02336763What this trial is testingRadiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver MetastasesWho this might be right forIris MelanomaMedium/Large Size Posterior Uveal MelanomaStage IIA Uveal Melanoma+4 more Jonsson Comprehensive Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00289016What this trial is testingTalimogene Laherparepvec in Stage IIIc and Stage IV Malignant MelanomaWho this might be right forMelanoma BioVex Limited 50
Testing effectiveness (Phase 2)Study completedNCT01961115What this trial is testingEpacadostat and Vaccine Therapy in Treating Patients With Stage III-IV MelanomaWho this might be right forMucosal MelanomaRecurrent MelanomaRecurrent Uveal Melanoma+8 more Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT02872259What this trial is testingBGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic MelanomaWho this might be right forMelanoma Haukeland University Hospital 74
Testing effectiveness (Phase 2)Study completedNCT00471887What this trial is testingTicilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV MelanomaWho this might be right forMelanoma (Skin) Jonsson Comprehensive Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT01082887What this trial is testingImmunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)Who this might be right forMetastatic Melanoma Nantes University Hospital 18
Testing effectiveness (Phase 2)Study completedNCT02500576What this trial is testingPembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic MelanomaWho this might be right forMetastatic MelanomaStage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7+1 more M.D. Anderson Cancer Center 18